Compare Danaher Corporation (DHR) vs MasterCard Inc (MA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs MasterCard Inc — how do they compare? Danaher Corporation trades at $200.2 (market cap $140.88B), while MasterCard Inc trades at $538.88 (market cap $475.39B). The key difference: MasterCard Inc is far larger — about 3.4× Danaher Corporation's market cap, and Danaher Corporation pays the higher dividend (0.8%). Which is the better fit depends on your goals.
| DHR | MA | |
|---|---|---|
Market Cap | $140.88B | $475.39B |
Sector | Health | Consumer Cyclical |
52-Week High | $242.05 | $598.96 |
52-Week Low | $161.91 | $471.55 |
Enterprise Value | $153.66B | $486.13B |
Dividend Yield | 0.8% | 0.65% |
Volume | — | 4,635,698 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $200.16, up 0.56% today, with a bullish technical signal from moving averages and strong analyst support. The company reported Q1 2026 EPS of $2.06, beating estimates of $1.94, marking the third consecutive quarterly beat. Revenue for 2025 was $24.57 billion with a net income margin of 14.89%, though margins have compressed from prior years. Recent news includes the acquisition of Masimo and a $172.5 million legal settlement finalized in April 2026.
The outlook remains positive with a consensus price target of $211.33, implying ~5.6% upside, supported by 69% buy ratings. Key risks include margin pressure, integration challenges from acquisitions, and macroeconomic sensitivity. The stock offers a dividend yield from its $0.40 quarterly payout, with solid cash flow generation offsetting debt levels.
Mastercard (MA) trades at $540.05, up 0.44% today, with a bullish technical outlook supported by moving averages and strong institutional buying. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $4.60 exceeding the $4.41 estimate. Revenue grew to $32.79B in 2025, and net income margins remain high at 45.88%. Analyst consensus is strongly bullish, with a $634.27 price target implying 17% upside.
The stock offers growth potential from digital payment expansion and AI initiatives, but faces risks from competitive disruption like stablecoins. High valuation multiples (P/E 31.14) require sustained execution. Institutional ownership trends and dividend stability support long-term confidence, though regulatory and macroeconomic shifts could pressure performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About MasterCard Inc
Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.
Read more on MA →
